Angus Chen has joined the firm as a partner in the New York office. Angus was previously at Haug Partners, where he was Chair of Life Sciences. Angus’s practice has focused on pharma and biopharma litigation for clients such as Chiesi, Takeda (Shire and Baxalta) and The Medicines company. He has a Ph.D. from Mt. Sinai School of Medicine in biochemistry. In addition to extensive trial experience in pharma and biopharma cases, Angus has extensive experience in PTAB proceedings, appellate work, and advising clients on patent and regulatory strategies, product lifecycle management, and complex settlement agreements.

See our latest News

Minh Nguyễn Hoàng

Permanent Residency or Citizenship in Vietnam: Choosing t...

November 6, 2024

Sareesh Rawat

Principle of Whole-Text Interpretation in Federal Contracts

November 6, 2024

Minh Nguyễn Hoàng

Unlocking Vietnamese Citizenship: A Comprehensive Guide t...

November 6, 2024

Minh Nguyễn Hoàng

From Foreigner to Citizen: Mastering the Naturalization P...

November 6, 2024

Minh Nguyễn Hoàng

Dual Citizenship in Vietnam: Possibilities, Limitations, ...

November 6, 2024

Alicea Castellanos

LEAVING THE U.S. IGNITES TAX COMPLICATIONS

November 5, 2024

Alicea Castellanos

SALIR DE ESTADOS UNIDOS DESATA COMPLICACIONES FISCALES

November 5, 2024

Minh Nguyễn Hoàng

Navigating Regulations: A Comprehensive Overview of Vietn...

November 4, 2024

Minh Nguyễn Hoàng

Privatization Potential: Uncovering Opportunities in Viet...

November 4, 2024

Sareesh Rawat

Apportioning Risk of Increased Performance Costs

November 2, 2024